Pharmaceutical Children suffering from prolonged, acute, convulsive seizures may not always receive timely rescue medication in schools and other community settings as intended by their specialist physician, according to the first findings of the PERFECT Initiative, which was organized and funded by USA-based ViroPharma (Nasdaq: VPHM). The results were presented as part of a symposium at the ILAE's 10th European Congress on Epileptology (ECE), in London, UK. 1 October 2012